| Cvs Pharmacy # 01889 | |
| 427 Washington Street, Brighton, Massachusetts 02135 | |
| (617) 783-2577 |
| Name | Cvs Pharmacy # 01889 |
|---|---|
| Organization Name | Cvs Pharmacy Inc |
| Location | 427 Washington Street, Brighton, Massachusetts 02135 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (617) 783-2577 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
BioTrends Research Group, Inc. is pleased to announce the publication of a new syndicated report, TreatmentTrends: Noninfectious Uveitis. This report, based on feedback gathered in an on-line survey completed by 72 retinal specialists in June/July 2010, addresses the medical management of noninfectious uveitis (anterior, intermediate, posterior and panuveitis) and referral/co-management patterns between retinal specialists and other specialties.
In patients with intracerebral hemorrhage —a type of stroke caused by bleeding inside the brain—transfusion with red blood cells may improve the chances of survival, reports a study in the May issue of Neurosurgery, official journal of the Congress of Neurological Surgeons.
People living in polluted urban areas are far less likely to be admitted to hospital with asthma when there are lots of trees in their neighborhood, a study by the University of Exeter's medical school has found.
In reports of two new studies, researchers led by Johns Hopkins say they have identified the mechanisms rooted in two anatomical brain abnormalities that may explain the onset of schizophrenia and the reason symptoms don't develop until young adulthood. Both types of anatomical glitches are influenced by a gene known as DISC1, whose mutant form was first identified in a Scottish family with a strong history of schizophrenia and related mental disorders. The findings could lead to new ways to treat, prevent or modify the disorder or its symptoms.
AVANIR Pharmaceuticals, Inc. today announced the presentation of detailed data, including safety and tolerability data from the open-label extension as well as cardiac safety data from the double-blind phase of the Phase III confirmatory STAR trial evaluating the investigational drug Zenvia™ (dextromethorphan/quinidine) in the treatment of pseudobulbar affect (PBA). The data were presented in two posters at the American Academy of Neurology (AAN) Annual Meeting in Toronto, Canada.
› Verified 1 days ago
| NPI Number | 1326147620 |
| Organization Name | CVS PHARMACY INC |
| Doing Business As | CVS PHARMACY # 01889 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 427 Washington St, Brighton, MA 02135 |
| Phone Number | 617-783-2577 |
News Archive
BioTrends Research Group, Inc. is pleased to announce the publication of a new syndicated report, TreatmentTrends: Noninfectious Uveitis. This report, based on feedback gathered in an on-line survey completed by 72 retinal specialists in June/July 2010, addresses the medical management of noninfectious uveitis (anterior, intermediate, posterior and panuveitis) and referral/co-management patterns between retinal specialists and other specialties.
In patients with intracerebral hemorrhage —a type of stroke caused by bleeding inside the brain—transfusion with red blood cells may improve the chances of survival, reports a study in the May issue of Neurosurgery, official journal of the Congress of Neurological Surgeons.
People living in polluted urban areas are far less likely to be admitted to hospital with asthma when there are lots of trees in their neighborhood, a study by the University of Exeter's medical school has found.
In reports of two new studies, researchers led by Johns Hopkins say they have identified the mechanisms rooted in two anatomical brain abnormalities that may explain the onset of schizophrenia and the reason symptoms don't develop until young adulthood. Both types of anatomical glitches are influenced by a gene known as DISC1, whose mutant form was first identified in a Scottish family with a strong history of schizophrenia and related mental disorders. The findings could lead to new ways to treat, prevent or modify the disorder or its symptoms.
AVANIR Pharmaceuticals, Inc. today announced the presentation of detailed data, including safety and tolerability data from the open-label extension as well as cardiac safety data from the double-blind phase of the Phase III confirmatory STAR trial evaluating the investigational drug Zenvia™ (dextromethorphan/quinidine) in the treatment of pseudobulbar affect (PBA). The data were presented in two posters at the American Academy of Neurology (AAN) Annual Meeting in Toronto, Canada.
› Verified 1 days ago
News Archive
BioTrends Research Group, Inc. is pleased to announce the publication of a new syndicated report, TreatmentTrends: Noninfectious Uveitis. This report, based on feedback gathered in an on-line survey completed by 72 retinal specialists in June/July 2010, addresses the medical management of noninfectious uveitis (anterior, intermediate, posterior and panuveitis) and referral/co-management patterns between retinal specialists and other specialties.
In patients with intracerebral hemorrhage —a type of stroke caused by bleeding inside the brain—transfusion with red blood cells may improve the chances of survival, reports a study in the May issue of Neurosurgery, official journal of the Congress of Neurological Surgeons.
People living in polluted urban areas are far less likely to be admitted to hospital with asthma when there are lots of trees in their neighborhood, a study by the University of Exeter's medical school has found.
In reports of two new studies, researchers led by Johns Hopkins say they have identified the mechanisms rooted in two anatomical brain abnormalities that may explain the onset of schizophrenia and the reason symptoms don't develop until young adulthood. Both types of anatomical glitches are influenced by a gene known as DISC1, whose mutant form was first identified in a Scottish family with a strong history of schizophrenia and related mental disorders. The findings could lead to new ways to treat, prevent or modify the disorder or its symptoms.
AVANIR Pharmaceuticals, Inc. today announced the presentation of detailed data, including safety and tolerability data from the open-label extension as well as cardiac safety data from the double-blind phase of the Phase III confirmatory STAR trial evaluating the investigational drug Zenvia™ (dextromethorphan/quinidine) in the treatment of pseudobulbar affect (PBA). The data were presented in two posters at the American Academy of Neurology (AAN) Annual Meeting in Toronto, Canada.
› Verified 1 days ago
Cvs Pharmacy #00055 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1927 Beacon Street, Brighton, Massachusetts 02135 Phone: (617) 738-6820 | |
Cvs Pharmacy # 01889 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 427 Washington Street, Brighton, Massachusetts 02135 Phone: (617) 783-2577 | |
Cvs Pharmacy # 03890 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 207 Market St, Brighton, Massachusetts 02135 Phone: (617) 254-0358 | |
Osco Pharmacy #4572 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 370 Western Ave, Brighton, Massachusetts 02135 Phone: (617) 782-1628 | |
Melvin Pharmacy Type: Community/Retail Pharmacy Location: 1558 Commonwealth Ave, Brighton, Massachusetts 02135 Phone: (617) 566-2281 |